[Laboratory and clinical evaluation of clindamycin-2-palmitate in pediatric field (author's transl)].
D000208:Acute Disease; D001991:Bronchitis / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000627:therapeutic use; D002981:Clindamycin / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D004352:Drug Resistance, Microbial; D004355:Drug Stability; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D010169:Palmitic Acids; D010612:Pharyngitis / Q000188:drug therapy*; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D014069:Tonsillitis / Q000188:drug therapy*
D010169:Palmitic Acids; D002981:Clindamycin; D002701:Chloramphenicol